Explain chain of transmission in infectious disease
chain of transmission infectious disease six links epidemiology

| Portal of Exit | Examples |
|---|---|
| Respiratory tract (coughing, sneezing) | TB, influenza, COVID-19, measles |
| Intestinal tract (feces) | Cholera, typhoid, hepatitis A, polio |
| Genitourinary tract (urine, secretions) | Gonorrhea, syphilis, typhoid (urinary carriers) |
| Skin/lesions (open wounds, vesicles) | Herpes, smallpox, impetigo |
| Blood | HIV, hepatitis B & C, malaria |
| Transplacental | Rubella, CMV, toxoplasma (TORCH agents), syphilis |
| Route | Mechanism | Examples |
|---|---|---|
| Vehicle-borne (food/water) | Contaminated food, water, milk, blood products | Cholera, typhoid, hepatitis A |
| Fomite-borne | Inanimate objects (clothing, syringes, doorknobs, toys) | Diphtheria, typhoid, hepatitis A |
| Vector-borne | Arthropod vectors | |
| - Mechanical | Passive carriage on insect body | Dysentery by flies |
| - Biological | Agent multiplies/develops in vector (e.g., Anopheles mosquito for malaria, Aedes for dengue/yellow fever, louse for typhus) | Malaria, dengue, plague |
| Airborne | Droplet nuclei (<5 µm) that remain suspended and travel far - e.g., TB, chickenpox, measles, COVID-19 | TB, varicella |
| Unclean hands | Hand-to-mouth, hand-to-food | Typhoid, staphylococcal infections, hepatitis A |
| Link | Intervention |
|---|---|
| Infectious agent | Antibiotics, antivirals, disinfection, sterilization |
| Reservoir | Case detection and treatment, carrier detection, animal culling, quarantine |
| Portal of exit | Respiratory precautions (masks), wound care, safe waste disposal |
| Mode of transmission | Vector control, safe food/water, hand hygiene, condom use, safe injection practice, isolation |
| Portal of entry | PPE, skin integrity, prophylactic vaccines/drugs |
| Susceptible host | Vaccination, chemoprophylaxis, improving nutrition, herd immunity |
Key principle: An infectious disease can only sustain itself in a population if the chain remains intact. The basic reproduction number (R₀) - the average number of secondary cases from one primary case in a fully susceptible population - reflects the overall efficiency of the chain. When R₀ > 1, the chain sustains; when < 1, the outbreak dies out.
Can you give me the corrected table for breaking the chain-public health interventions
| Link | Goal | Key Interventions |
|---|---|---|
| 1. Infectious Agent | Destroy or neutralize the agent | Antibiotics/antivirals/antifungals; disinfection of surfaces; sterilization of instruments; pasteurization of food/milk |
| 2. Reservoir | Eliminate or control the source | Case detection, isolation and treatment; carrier detection and treatment; animal reservoir control (culling, vaccination of animals); environmental sanitation; quarantine of exposed persons |
| 3. Portal of Exit | Prevent the agent from leaving the reservoir | Wound dressings and covering lesions; respiratory hygiene (covering mouth/nose when coughing/sneezing); safe disposal of infected secretions, feces, urine, and blood; proper handling of blood and body fluids |
| 4. Mode of Transmission | Interrupt transfer between reservoir and host | Contact: hand hygiene, gloves, barrier precautions, condom use; Droplet/Airborne: masks, negative-pressure isolation rooms, ventilation; Vehicle-borne: safe water supply, food safety, sewage disposal; Vector-borne: insecticides, bed nets, larval control, environmental drainage; Fomite: disinfection of shared objects; safe injection practices (needle exchange) |
| 5. Portal of Entry | Block the agent from entering a new host | PPE (gloves, masks, eye protection, gowns); intact skin maintenance; urinary catheter care; wound care; pre-exposure prophylaxis (e.g., PrEP for HIV, rabies post-exposure prophylaxis) |
| 6. Susceptible Host | Increase host resistance | Vaccination (active immunization); passive immunization (immunoglobulins); chemoprophylaxis (e.g., malaria prophylaxis, INH for TB contacts); nutritional support; management of underlying conditions (diabetes, HIV); herd immunity through high vaccination coverage |
Give a more detailed classification of vector borne diseases
| Example | Vector | Disease |
|---|---|---|
| Scabies | Itch mite (Sarcoptes scabiei) | Scabies |
| Pediculosis | Louse (Pediculus) | Head/body lice infestation |
| Vector | Diseases Transmitted Mechanically |
|---|---|
| Housefly (Musca domestica) | Typhoid, paratyphoid, diarrhea, dysentery, cholera, amoebiasis, poliomyelitis, trachoma, conjunctivitis |
| Cockroaches | Enteric pathogens (salmonella, shigella, E. coli) |
Key point: The agent does NOT need an extrinsic incubation period in mechanical transmission. The vector can transmit immediately.
| Example | Agent | Vector |
|---|---|---|
| Plague | Yersinia pestis (bacilli multiply in rat flea gut) | Rat flea (Xenopsylla cheopis) |
| Epidemic typhus | Rickettsia prowazekii (multiplies in louse gut) | Body louse |
| Example | Agent | Vector | Change |
|---|---|---|---|
| Malaria | Plasmodium spp. | Anopheles mosquito | Undergoes sexual cycle (gametocytes → oocyst → sporozoites) + multiplication |
| Sleeping sickness | Trypanosoma brucei | Tsetse fly (Glossina) | Cyclical development + multiplication |
| Chagas disease | Trypanosoma cruzi | Reduviid bug (Triatoma) | Development + multiplication |
| Leishmaniasis | Leishmania spp. | Sandfly (Phlebotomus) | Promastigote ↔ amastigote transformation + multiplication |
| Example | Agent | Vector | Change |
|---|---|---|---|
| Filariasis | Wuchereria bancrofti | Culex mosquito | Microfilaria → infective L3 larva (no increase in number) |
| Guinea worm | Dracunculus medinensis | Cyclops (copepod) | Larval development only |
| Loiasis | Loa loa | Mango fly (Chrysops) | L1 → L3 larval stage |
Transovarial + transstadial transmission together allow ticks to act as both reservoir AND vector, making them especially dangerous epidemiologically.
| Vector | Order | Disease(s) Transmitted | Type of Transmission |
|---|---|---|---|
| Anopheles mosquito | Diptera | Malaria, filaria | Biological (cyclo-propagative / cyclo-developmental) |
| Aedes mosquito | Diptera | Dengue, yellow fever, Zika, chikungunya, dengue haemorrhagic fever, West Nile | Biological (propagative) |
| Culex mosquito | Diptera | Filariasis, Japanese encephalitis, West Nile fever | Biological (cyclo-developmental / propagative) |
| Housefly (Musca) | Diptera | Typhoid, dysentery, cholera, trachoma, polio | Mechanical |
| Sandfly (Phlebotomus) | Diptera | Kala-azar (visceral leishmaniasis), oriental sore (cutaneous leishmaniasis), sandfly fever, Oroya fever | Biological (cyclo-propagative) |
| Blackfly (Simulium) | Diptera | Onchocerciasis (river blindness) | Biological (cyclo-developmental) |
| Tsetse fly (Glossina) | Diptera | Sleeping sickness (African trypanosomiasis) | Biological (cyclo-propagative) |
| Mango fly (Chrysops) | Diptera | Loiasis | Biological (cyclo-developmental) |
| Body louse (Pediculus humanus) | Phthiraptera | Epidemic typhus (R. prowazekii), relapsing fever (Borrelia recurrentis), trench fever | Biological (propagative); scratching-in of infected feces |
| Rat flea (Xenopsylla cheopis) | Siphonaptera | Bubonic plague, endemic (murine) typhus, hymenolepiasis | Biological (propagative) |
| Reduviid bug (Triatoma spp.) | Hemiptera | Chagas disease (T. cruzi) | Biological (cyclo-propagative); fecal contamination of bite wound |
| Cockroach | Blattodea | Enteric pathogens | Mechanical |
| Vector | Type | Disease(s) Transmitted | Notes |
|---|---|---|---|
| Hard tick (Ixodes, Dermacentor, Haemaphysalis) | Acarina | Lyme disease, Rocky Mountain spotted fever, tick typhus, viral encephalitis, tularemia, tick paralysis, human babesiosis, Kyasanur Forest disease | Transstadial + transovarial transmission; act as reservoir |
| Soft tick (Ornithodoros) | Acarina | Relapsing fever (Borrelia spp.), Q fever (Coxiella burnetii) | Feed quickly; long-lived; maintain infection transovarially |
| Trombiculid mite (chigger) | Acarina | Scrub typhus (Orientia tsutsugamushi), rickettsial pox | Larval stage bites; transovarial transmission in mite |
| Itch mite (Sarcoptes scabiei) | Acarina | Scabies | Direct contact; burrows in skin |
| Vector | Disease | Notes |
|---|---|---|
| Cyclops (copepod, Cyclops spp.) | Guinea worm disease (Dracunculus), fish tapeworm (Diphyllobothrium latum) | Ingested in contaminated water; intermediate host |
BIOLOGICAL TRANSMISSION
├── Propagative → Agent multiplies only (no form change)
│ e.g., Plague in rat flea
├── Cyclo-propagative → Agent multiplies + changes form
│ e.g., Malaria in Anopheles
└── Cyclo-developmental → Agent changes form only (no multiplication)
e.g., Filaria in Culex mosquito
What is healthy carrier
"Healthy carriers emerge from subclinical cases. They are victims of subclinical infection who have developed a carrier state without suffering from overt disease, but are nevertheless shedding the disease agent."
- Park's Textbook of Preventive and Social Medicine
| Situation | Example |
|---|---|
| Subclinical infection → carrier state | Poliomyelitis - person sheds poliovirus in stool without ever developing paralytic disease |
| Subclinical infection → NO carrier state | Tuberculosis - most persons with a positive tuberculin test do not actively disseminate tubercle bacilli and are therefore NOT labelled as carriers |
| Disease | Organism | Notes |
|---|---|---|
| Poliomyelitis | Poliovirus | Most infections are subclinical; carrier sheds virus in feces - major source of community spread |
| Cholera | Vibrio cholerae | Healthy carriers shed vibrio in stool; important reservoir in endemic areas |
| Meningococcal meningitis | Neisseria meningitidis | Nasopharyngeal carriage in up to 10-35% of population; most never develop meningitis |
| Salmonellosis | Salmonella spp. | Intestinal carrier state after asymptomatic infection |
| Diphtheria | Corynebacterium diphtheriae | Pharyngeal/nasal carriage without disease |
| Hepatitis B | HBV | "Healthy carrier" = HBsAg positive, anti-HBe positive, HBeAg negative, normal liver enzymes, low/undetectable viral DNA, no liver damage on biopsy |
| Typhoid | Salmonella typhi | Can progress to chronic carrier state (via gall bladder colonization) without ongoing symptoms |
CARRIERS (by type)
├── Incubatory carrier → Sheds during incubation period (before symptoms appear)
│ e.g., measles, mumps, hepatitis B
├── Convalescent carrier → Sheds during recovery (after symptoms)
│ e.g., typhoid, cholera, dysentery
└── HEALTHY CARRIER → Never had symptoms at any stage; sheds from subclinical infection
e.g., polio, cholera, meningococcal meningitis
CARRIERS (by duration)
├── Temporary carrier → Sheds for a short period (includes most healthy carriers)
└── Chronic carrier → Sheds for months/years (e.g., typhoid via gall bladder, HBV)
CARRIERS (by portal of exit)
├── Intestinal carrier
├── Urinary carrier
├── Respiratory/nasal carrier
└── Blood/skin carrier
All healy
All healthy carriers develop from sub clinical infection
"Healthy carriers emerge from subclinical cases. They are victims of subclinical infection who have developed carrier state without suffering from overt disease."
Not every subclinical infection produces a healthy carrier.
Subclinical infection → MAY → Healthy carrier state ✓
Subclinical infection → MAY → No carrier state at all ✓
Healthy carrier ← ALWAYS ← Subclinical infection ✓
| Scenario | Example | Outcome |
|---|---|---|
| Subclinical infection → carrier state | Poliomyelitis | Person sheds poliovirus in feces without ever developing paralysis - IS a healthy carrier |
| Subclinical infection → NO carrier state | Tuberculosis | Positive tuberculin test = subclinical infection, but most do not shed tubercle bacilli actively and are therefore NOT labelled as carriers |
"It is well to remember that a person whose infection remains subclinical may or may not be a carrier. In polio, the infection may remain subclinical and the person may act as a temporary carrier. On the other hand, in tuberculosis, most persons with a positive tuberculin test do not actively disseminate tubercle bacilli and therefore are not labelled as carriers."
| Assertion | Verdict |
|---|---|
| All healthy carriers develop from subclinical infection | TRUE - by definition |
| All subclinical infections produce healthy carriers | FALSE - subclinical infection is necessary but not sufficient |
| A person with subclinical TB is a healthy carrier | FALSE - subclinical does not equal carrier |
Active vs passive carrier
| Classification Axis | Types |
|---|---|
| By clinical status | Incubatory / Convalescent / Healthy (subclinical) |
| By duration | Temporary / Chronic |
| By portal of exit | Intestinal / Urinary / Respiratory / Nasal |
| Context | Meaning |
|---|---|
| Infectious disease epidemiology | "Active/passive carrier" is not a standard classification - use incubatory, convalescent, healthy, temporary, or chronic carrier instead |
| Membrane physiology/pharmacology | Active = energy-dependent transport; Passive = facilitated diffusion |
What is droplet nuclei
"Droplet nuclei are tiny particles (1-10 microns range) that represent the dried residue of droplets."
- Park's Textbook of Preventive and Social Medicine
| Source | Examples |
|---|---|
| Natural expiratory efforts | Coughing, sneezing, talking, singing |
| Purposeful aerosolization | Atomizing devices, nebulizers |
| Accidental generation | Microbiological laboratories, abattoirs, rendering plants, autopsy rooms |
| Healthcare procedures | Bronchoscopy, sputum induction, irrigation of tuberculous abscesses |
Large respiratory droplet (>5 µm)
↓ evaporation of water content
Droplet nucleus (<5 µm) → remains airborne → inhaled by susceptible host
| Property | Detail |
|---|---|
| Size | 1-5 µm (particles in this range reach the alveoli); Park's cites 1-10 µm range overall |
| Settling rate | Extremely slow - 0.5 mm/s or less, allowing transport over significant distances |
| Behavior | Remain suspended in air for long periods; disseminated by air currents far from point of origin |
| Susceptibility | Highly susceptible to germicidal levels of ultraviolet (UV) light |
| Lung penetration | Small size allows them to bypass bronchial defenses and reach terminal alveolar macrophages |
| Feature | Droplets | Droplet Nuclei |
|---|---|---|
| Size | >5 µm (large) | <5 µm (tiny) |
| Water content | Contain water | Dried residue after evaporation |
| Behavior in air | Settle out quickly due to gravity | Remain suspended for long periods |
| Distance traveled | Short range - only 30-60 cm from source | Long range - carried by air currents across rooms/buildings |
| Site of deposition | Deposited on mucosa of upper airway, conjunctiva | Penetrate deep to terminal alveoli |
| Precaution needed | Surgical mask, distance | N95 respirator, negative-pressure room, ventilation |
| Examples | Meningococcal meningitis, pertussis, diphtheria, common cold, pneumococcal pneumonia | TB, measles, varicella, smallpox, COVID-19 (to some extent), Q fever |
Larger respiratory droplets are trapped in the mucociliary elevator of the upper airways and expelled. The fairly tortuous, branched path of the bronchial tree ensures this. It is the small droplet nuclei that slip through to the alveoli. - Fishman's Pulmonary Diseases and Disorders
| Disease | Pathogen | Notes |
|---|---|---|
| Tuberculosis | Mycobacterium tuberculosis | The classic example; 1-3 bacilli per droplet nucleus are sufficient to cause infection; Riley's guinea pig experiment (1950s) proved exclusive airborne transmission |
| Measles | Measles virus (Paramyxovirus) | Highly infectious; can remain airborne in a room for up to 2 hours |
| Varicella (Chickenpox) | Varicella-zoster virus | Airborne + direct contact |
| Smallpox | Variola virus | Eradicated but historically transmitted by droplet nuclei |
| Q Fever | Coxiella burnetii | Extremely infectious by aerosol; single organism can cause infection |
| Influenza | Influenza virus | Both droplets and droplet nuclei |
| COVID-19 | SARS-CoV-2 | Evidence for both larger droplet and airborne droplet nuclei transmission |
| Factor | Effect |
|---|---|
| Sputum smear AFB positivity | More organisms → more infectious droplet nuclei |
| Cough strength and frequency | More forceful coughing generates more nuclei |
| Presence of lung cavitation | Cavities harbor large bacterial loads |
| Room volume and ventilation | Poor ventilation concentrates nuclei |
| Humidity | Affects survival of organisms in nuclei |
| UV light exposure | Kills organisms in nuclei |
| Duration of contact with infected air | Longer exposure = greater risk |